Pleasanton, Calif.-based The Permanente Medical Group, part of Kaiser Permanente, has launched Permanentech, a physician-led healthcare innovation company focused on developing and scaling AI-powered technologies and care delivery solutions.
The company will develop strategic partnerships and joint ventures with technology companies, as well as incubate and launch new businesses built around innovations developed within the medical group, according to a Nov. 16 news release shared with Becker’s.
Permanentech is a wholly owned subsidiary of The Permanente Medical Group, which includes approximately 10,000 physicians caring for 4.7 million Kaiser Permanente members in Northern California.
The company will focus on AI-enabled technologies designed to improve patient access, care quality and operational efficiency. Its model allows physicians and frontline clinicians to develop solutions, test them within Oakland, Calif.-based Kaiser Permanente and potentially expand their use to other health systems.
“Our clinicians are continuously innovating and refining how we deliver care,” Kenneth Trauner, MD, CEO of Permanentech and chief innovation officer at The Permanente Medical Group, said in the news release. “Permanentech gives them a dedicated resource to rapidly turn their insights and creativity into scalable solutions that benefit both our patients and the wider health care community.”
Permanentech will operate across two areas: partnering with established and early-stage technology companies to co-develop and validate solutions, and building independent companies around innovations originating within the medical group.
Its first portfolio company, Wrapt Health, developed an AI-enabled tool designed to reduce missed cancer infusion appointments.
The technology originated from a physician-developed predictive model that identifies patients likely to miss appointments, allowing care teams to intervene earlier and offer available infusion slots to other patients.
Permanentech has since rebuilt the tool into an automated solution intended for use within Kaiser Permanente and other health systems. The medical group operates 22 infusion sites with 524 chairs across Northern California.
The company plans to introduce additional portfolio companies and joint ventures with technology partners in the coming months.